Filing Details
- Accession Number:
- 0001209191-23-035617
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-08 21:35:39
- Reporting Period:
- 2021-03-16
- Accepted Time:
- 2023-06-08 21:35:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1094038 | Marker Therapeutics Inc. | MRKR | Pharmaceutical Preparations (2834) | 880277072 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1270905 | David Norman Eansor | C/O Marker Therapeutics, Inc. 4551 Kennedy Commerce Drive Houston TX 77032 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-16 | 14,285 | $17.50 | 16,713 | No | 4 | P | Direct | |
| Common Stock | Disposition | 2021-03-25 | 14,285 | $0.00 | 2,428 | No | 4 | G | Direct | |
| Common Stock | Acquisiton | 2021-03-25 | 7,142 | $0.00 | 7,142 | No | 4 | G | Indirect | By the John R. Eansor 2020 Exempt Trust |
| Common Stock | Acquisiton | 2021-03-25 | 7,142 | $0.00 | 7,142 | No | 4 | G | Indirect | By the Scott Eansor 2020 Exempt Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | G | Direct | |
| No | 4 | G | Indirect | By the John R. Eansor 2020 Exempt Trust |
| No | 4 | G | Indirect | By the Scott Eansor 2020 Exempt Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2023-06-06 | 8,000 | $0.00 | 8,000 | $1.72 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,000 | 2033-06-05 | No | 4 | A | Direct |
Footnotes
- Reflects a 10-1 reverse stock split which became effective on January 16, 2023.
- The Reporting Person transferred these shares to a trust of which the Reporting Person is the trustee. The Reporting Person's immediate family is the sole beneficiary of the trust.
- This option vests on June 6, 2024, subject to the Reporting Person's continued service as a director through the vesting date.
Billionaire Hedge Funds
